🐻 UNH $10.7M Bear Call Spread - Institutional Money Betting on Continued Downside!

📅 January 27, 2026 | 🔥 Unusual Activity Detected

---

🎯 The Quick Take

Someone just put on a $10.7M bear call spread on UNH this morning at 09:41:21 - selling 6,699 contracts of the $330 calls and buying 6,699 contracts of the $360 calls, both expiring May 15th. The trader collected a $3.3M net credit, betting that UNH stays below $330 by May expiration. This trade landed on the same day UNH reported Q4 earnings, missed revenue estimates, and issued guidance calling for the first revenue decline in a decade - sending shares down ~20% to $284.

---

📊 Company Overview

UnitedHealth Group (UNH) is the largest private health insurer in the United States and a diversified healthcare giant:

• Market Cap: ~$254.5B (down sharply from $318B earlier this month)
• Industry: Hospital & Medical Service Plans
• Current Price: $284.11 (down ~20% intraday)
• 52-Week Range: $234.60 - $606.36
• Primary Business: Health insurance (UnitedHealthcare, ~49.8M members) + healthcare services (Optum, ~90,000 physicians, Optum Rx pharmacy benefits)

---

💰 The Option Flow Breakdown

📊 What Just Happened

The Tape (January 27, 2026 @ 09:41:21) - Bear Call Spread:

🤓 What This Actually Means

This is a bear call spread - a defined-risk bearish strategy. Let me break it down:

• 💰 Net credit received: $3.3M ($7.0M collected from selling $330 calls minus $3.7M paid for $360 calls)
• 📏 Spread width: $30 ($330 to $360) = $20.1M max risk on 6,699 contracts
• 🎯 Max profit: $3.3M - achieved if UNH stays below $330 at May 15th expiration
• 📉 Max loss: $16.8M - occurs if UNH rises above $360 by expiration
• 🛡️ Breakeven: ~$334.91 (short strike + net credit per share of $4.91)
• ⚡ Both strikes above current price: $330 is 16.2% above $284.11, $360 is 26.7% above

What's really happening here:

This trader is saying: "UNH is NOT going back to $330 by May." Given that UNH just cratered 20% on terrible earnings and forward guidance, they're getting paid $3.3M to bet the stock doesn't recover its pre-earnings levels within 4 months. Both legs executed at the MID price simultaneously - this is clean institutional execution, not retail.

Unusual Score: 🔥 EXTREME - The $330 call leg has a Z-score of 228.88 and the $360 call leg has a Z-score of 49.37. Both classified as EXTREMELY UNUSUAL. Volume-to-OI ratios of 8.9x and 8.1x respectively show this is fresh positioning, not rolling existing trades. The $330 leg saw volume of 6,700 contracts against only 749 open interest - that's nearly 9x the entire existing position. This kind of size shows up only a few times a year for UNH options.

---

📈 Technical Setup / Chart Check-Up

1-Year Performance Chart

UNH is in a brutal downtrend. The stock was the worst-performing Dow Jones component in 2025, dropping 32% for the year. After trading around $330-$350 in November/December 2025, shares have now been cut in half from their all-time high of $607.89 set in November 2024. Today's 20% intraday plunge on earnings and CMS rate news adds insult to injury.

Key observations:

• 📉 Relentless selling: From $606 high to $284 - a 53% peak-to-trough decline in ~14 months
• 💀 No support holding: Every bounce attempt has been sold aggressively
• ⚠️ Record volume today: Massive institutional liquidation on earnings miss + CMS rate proposal
• 🎢 Volatility expanding: Daily moves getting larger as uncertainty compounds

🔵 Gamma-Based Support & Resistance Analysis

Current Price: $281.56

The gamma exposure map shows where options market makers have concentrated risk, creating natural price magnets and barriers:

🔵 Support Levels (Put Gamma Below Price):

• $280 - Immediate support with strongest nearby put gamma (6.2B put GEX). This is the current floor - dealers will buy dips aggressively here
• $270 - Secondary support at 4.8B put gamma (4.1% below current price)
• $260 - Deeper support with 2.4B put gamma (7.7% below)
• $250 - Extended floor at 2.9B put gamma (11.2% below)
• $240 - Disaster level at 1.3B put gamma (14.8% below)

🟠 Resistance Levels (Call Gamma Above Price):

• $290 - First resistance at 4.4B total gamma (3.0% above) - initial bounce target
• $300 - Major resistance with 15.4B total gamma (STRONGEST LEVEL - 6.6% above). This is the wall
• $310 - Secondary ceiling at 6.8B gamma (10.1% above)
• $320 - Heavy resistance at 5.4B gamma (13.7% above)
• $330 - The short strike of this bear call spread sits at 4.1B gamma (17.2% above)

What this means for traders:

The gamma data shows massive resistance building between $290-$310, with $300 being the single strongest level. For UNH to reach the $330 short strike of this bear call spread, it would need to punch through MULTIPLE gamma walls - the $290, $300, $310, and $320 resistance zones. That's a LOT of overhead supply. The trader's bet that UNH stays below $330 is well-supported by the gamma landscape.

Net GEX Bias: Bearish (45.8B call gamma vs 57.5B put gamma) - More put gamma than call gamma confirms the market is positioned defensively.

📊 Implied Move Analysis

Options market pricing for upcoming expirations:

• 📅 Weekly (Jan 30 - 3 days): +/-3.36% (+/-$9.46) -> Range: $271.76 - $290.68
• 📅 Monthly OPEX (Feb 20 - 24 days): +/-6.32% (+/-$17.76) -> Range: $263.46 - $298.99
• 📅 Triple Witch (Mar 20 - 52 days): +/-8.99% (+/-$25.29) -> Range: $255.93 - $306.51
• 📅 May OPEX (May 15 - THIS TRADE!): Upper range ~$314.95, lower range ~$247.49
• 📅 Yearly LEAPS (Dec 18 - 325 days): +/-23.12% (+/-$65.02) -> Range: $216.20 - $346.25

Translation for regular folks:

The options market is pricing in big moves ahead - a potential ~9% swing over the next 2 months and up to 23% over the year. For the May 15th expiration (when this trade settles), the implied upper range is about $315 - which is STILL below the $330 short strike! The market itself doesn't expect UNH to reach $330 by May based on current implied volatility pricing.

This is exactly why the bear call spread trader feels comfortable selling the $330 strike. Even the options market's "best case" implied move doesn't get UNH back to $330. They'd need a 16%+ rally from here - possible but unlikely given the fundamental headwinds.

---

🎪 Catalysts

🔴 Recent Catalysts (Already Happened)

Q4 2025 Earnings - January 27, 2026 (TODAY) 📊

• 📉 Revenue missed: $113.2B vs $113.82B consensus
• 💰 Adjusted EPS roughly in-line at $2.11 vs $2.10-$2.12 expected
• 😰 GAAP EPS of just $0.01 - hammered by $1.6B in one-time charges (restructuring + cyberattack costs)
• 📉 2026 revenue guidance: >$439B vs $454.6B consensus - a massive miss AND a YoY decline
• 💀 CFO called it "the first time in a decade that UnitedHealth Group has had declining revenue"
• 📊 Full-year 2025 medical care ratio hit 89.1%, up 340 bps YoY - margins under serious pressure

CMS Medicare Advantage 2027 Rate Proposal - January 26, 2026 📉

• 😱 CMS proposed a near-flat 0.09% MA payment increase for 2027 - the industry expected 4-6%!
• 🚨 CMS also proposed eliminating chart review-based diagnoses from risk adjustment - directly targeting a key UNH revenue strategy
• 📉 This double-whammy (earnings miss + CMS rates) triggered the 20% selloff

Leadership Overhaul (2025)

• 👔 CEO Andrew Witty resigned May 2025, replaced by Stephen Hemsley (returning CEO from 2006-2017)
• 💼 CFO Wayne DeVeydt replaced John Rex in September 2025
• 🏥 Dr. Patrick Conway became Optum CEO in May 2025
• Complete C-suite overhaul creates execution uncertainty during a critical turnaround period

🔮 Upcoming Catalysts (Next 6 Months)

Other key developments to watch:

• ⚖️ DOJ antitrust investigation into UNH's vertical integration (UnitedHealthcare + Optum's ~90,000 physicians) remains ongoing. Staff reductions at DOJ have delayed the probe, but any monopolization suit or settlement would be a major catalyst.
• 🚨 DOJ criminal/civil Medicare billing investigation expanded to include Optum Rx and physician reimbursement. Criminal charges would be devastating.
• 📋 PBM reform legislation could impact Optum Rx (~$146B revenue in 2025)
• 🏥 UNH withdrew from MA markets in 109 counties across 16 states for 2026, impacting ~180,000 seniors

---

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, and the current catalyst environment, here are the scenarios through May 15th expiration:

📉 Bear Case (35% probability)

Target: $230-$260

How we get there:

• 😰 CMS finalizes 2027 MA rates near the 0.09% proposal in April - confirms structurally lower funding
• 🚨 DOJ criminal investigation escalates - formal charges or expanded scope
• 📉 Q1 2026 earnings show medical care ratio NOT improving from 89.1% - turnaround thesis fails
• 💀 Chart review elimination proposal finalized - removes key revenue mechanism
• 📊 Break below $280 gamma support triggers cascade to $270, then $260

Bear call spread P&L: Full $3.3M max profit (both legs expire worthless)

🎯 Base Case (45% probability)

Target: $270-$310 range (CHOPPY CONSOLIDATION)

Most likely scenario:

• ✅ Stock finds footing around $270-$290 gamma support zone after today's crash
• ⚖️ CMS revises 2027 MA rates slightly higher (1-2% vs 0.09%) providing some relief but still below expectations
• 📊 Medical care ratio shows modest improvement toward 88.8% target - turnaround is slow but progressing
• 🏥 New leadership team executes operationally, stabilizing narrative but not inspiring confidence yet
• 🔄 Stock chops between $270 support and $300 resistance (strongest gamma level) through May

Bear call spread P&L: Full $3.3M max profit (stock stays well below $330)

📈 Bull Case (20% probability)

Target: $310-$340

How we get there:

• 🚀 CMS finalizes 2027 MA rates at 3-4% increase (massive relief rally for entire managed care sector)
• 💪 Q1 2026 earnings show MCR dropping to 88.5% or better - turnaround ahead of schedule
• ⚖️ DOJ investigation settles with manageable fine (no structural changes required)
• 📈 Analyst upgrades flood in as stock trades at historically cheap 18x P/E with improving fundamentals
• 🎯 Stock needs to break through $290, $300, $310, AND $320 gamma walls to reach $330

Bear call spread P&L: If UNH hits $330, spread is at breakeven (~$334.91). Above $335, trader starts losing. Above $360, max loss of $16.8M.

Why bull case is only 20%: UNH would need to rally 16%+ from here through multiple gamma resistance levels while facing declining revenue for the first time in a decade, an expanding DOJ criminal probe, and CMS rate headwinds. The implied move data shows the market's upper range for May at ~$315, which is still below $330.

---

💡 Trading Ideas

🛡️ Conservative: The "Watch and Wait" Approach

Play: Stay on sidelines until CMS rate finalization in early April provides clarity on Medicare Advantage economics

Why this works:

• ⏰ Stock just crashed 20% on earnings - catching a falling knife here is dangerous
• 📊 DOJ investigation creates binary risk that's impossible to quantify or time
• 🎯 CMS rate finalization in early April will determine whether the entire managed care business model is viable
• 🛡️ No insider buying during a 50%+ drawdown from highs - management isn't stepping up
• 💡 Better entries likely at $250-$260 if CMS rates disappoint further

Action plan:

• 👀 Monitor CMS final rate announcement (early April 2026) as the key catalyst
• 🎯 If rates come in at 2%+ increase, consider buying shares at $270-$280 level with $250 stop
• ❌ If rates stay near 0.09%, stock likely heads to $250 or lower - stay away
• 📊 Watch Q1 2026 earnings (late April) for medical care ratio trend

Risk level: Minimal (cash position) | Skill level: Beginner-friendly

⚖️ Balanced: Copy the Institutional Spread (Sell Premium)

Play: Sell a smaller version of this bear call spread - same structure, retail-sized

Structure: Sell UNH May 15 $330 call, Buy UNH May 15 $360 call

Why this works:

• 🤝 You're taking the exact same position as the institution that just deployed $10.7M
• 📏 Both strikes are 16-27% above current price - stock needs a massive rally to hurt you
• 💰 Collect ~$4.91/share credit ($491 per 1-lot spread)
• 📉 Max risk: $25.09/share ($2,509 per 1-lot) if UNH somehow rockets above $360
• ⏰ 108 days to expiration - time decay works in your favor every single day
• 📊 Implied move and gamma levels both suggest $330 is unreachable by May

Estimated P&L per 1-lot:

• 💰 Max profit: $491 (stock stays below $330 - most likely outcome)
• 📉 Max loss: $2,509 (stock above $360 - very unlikely scenario)
• 🎯 Breakeven: $334.91

Position sizing: 1-3 spreads max for a $25K-$50K account. Never risk more than 5% of portfolio on a single trade.

Risk level: Moderate (defined risk, bearish directional) | Skill level: Intermediate

🚀 Aggressive: Buy Puts on the Bounce

Play: If UNH bounces to $290-$300 gamma resistance zone, buy May puts

Structure: Buy UNH May 15 $280 puts on any rally to $290-$300

Why this could work:

• 📊 $300 strike has the STRONGEST gamma resistance (15.4B total gamma) - natural ceiling
• 😰 Fundamental picture remains terrible: declining revenue, DOJ criminal probe, CMS rate pressure
• 🎯 Buying puts on a bounce lets you enter with better risk/reward vs chasing today's crash
• ⏰ May expiration captures both CMS rate finalization and Q1 earnings

Why this could blow up:

• 💸 Implied volatility is VERY high after today's crash - puts are expensive
• 📈 Any positive CMS rate revision or DOJ settlement could trigger 10-15% rally
• 🎢 Short squeeze risk in heavily-shorted managed care names
• 💀 Total loss if UNH rallies and stays above $280

Risk level: HIGH (directional bet, expensive premiums) | Skill level: Advanced

---

⚠️ Risk Factors

Don't get caught by these potential landmines:

• 📈 CMS rate revision could spark massive rally: The 0.09% proposed rate is just a proposal. Final rates come in early April 2026. If CMS bumps rates to 2-3%, the entire managed care sector could rally 15-20% in a day. This is the single biggest risk to the bear call spread thesis.

• ⚖️ DOJ investigation remains a wildcard both ways: The criminal Medicare billing probe and antitrust investigation could result in anything from dismissal (bullish) to structural separation (catastrophic). Impossible to handicap timing or outcome.

• 💊 Valuation getting "cheap" for contrarians: At ~18x P/E vs historical 22-25x average, value investors may see an entry point. Consensus price target is still ~$408 (though expect massive revisions downward after today). If a few big analysts upgrade on valuation alone, could trigger a relief rally.

• 📉 Medical cost trend may NOT stabilize: Management is targeting 88.8% MCR for 2026, but 2025 came in at 89.1% and the trend has been moving the wrong direction for 2 years. If Q1 2026 MCR comes in above 89%, the turnaround thesis is dead and the stock likely revisits $250.

• 🏥 Reputational and political headwinds: The aftermath of the December 2024 Brian Thompson assassination created unprecedented public hostility toward health insurers. Political pressure for prior authorization reform and PBM overhaul adds regulatory risk on top of CMS rate pressure.

• 📊 No insider buying despite 50%+ decline: Zero insider purchases in the last 90 days during a massive drawdown from $607 to $284. When management won't buy their own stock at these levels, that tells you something.

---

🎯 The Bottom Line

Real talk: This $10.7M bear call spread is a clean, professional trade that says: "UNH is NOT bouncing back to $330 anytime soon." And honestly? It's hard to argue with that thesis right now.

What this trade tells us:

• 🎯 Institutional money sees a ceiling well below $330 for the next 4 months
• 💰 They're collecting $3.3M in premium, betting the headwinds are too strong for a meaningful recovery
• ⚖️ The defined-risk structure (capped at $16.8M loss) shows discipline - they're not going all-in bearish, just selling expensive upside
• 📊 Both legs executed at MID price simultaneously with matching 6,699 contract size - textbook institutional spread execution

The fundamental picture is rough:

• 📉 First revenue decline in a decade
• 🚨 CMS proposing near-flat Medicare Advantage rates
• ⚖️ DOJ criminal investigation expanding
• 💀 Medical care ratio at 89.1% and rising
• 👔 Complete C-suite overhaul in 2025

But don't get too comfortable on the bear side either. CMS rate finalization in early April could change everything. If rates come in significantly above 0.09%, managed care stocks could rip higher.

Mark your calendar - Key dates:

• 📅 January 31, 2026 - NewYork-Presbyterian contract deadline
• 📅 Early April 2026 - CMS finalizes 2027 Medicare Advantage rates (THE catalyst)
• 📅 Late April 2026 - Q1 2026 earnings (first quarter under new guidance)
• 📅 May 15, 2026 - Bear call spread expiration day

Final verdict: The smart money isn't betting on an UNH recovery anytime soon - and the data backs them up. Gamma resistance, implied move pricing, and the fundamental picture all point to UNH staying below $330 through May. The biggest risk is a CMS rate surprise in April. If you're an UNH shareholder, this is a signal to manage your expectations. If you're looking to trade, selling premium above $320-$330 looks like the highest-probability play based on current positioning.

Be patient with UNH. The turnaround story needs actual evidence - not just hope. 💪

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance doesn't guarantee future results. Bear call spreads have defined but potentially large losses if the stock rallies significantly. The institutional trader may have complex portfolio hedging needs not applicable to retail traders. Always do your own research and consider consulting a licensed financial advisor before trading.

---

About UnitedHealth Group: UnitedHealth Group is the largest private health insurer in the United States, providing medical benefits to approximately 51 million members globally. Through its Optum subsidiary, UNH operates one of the largest physician networks (~90,000 doctors), a top-3 pharmacy benefit manager (Optum Rx), and healthcare technology services. Market cap ~$254.5B in the Hospital & Medical Service Plans industry.